Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$77.5K Sell
1,234
-524
-30% -$36.5K 0.01% 611
2025
Q4
$117K Sell
1,758
-72
-4% -$4.66K 0.01% 522
2025
Q3
$123K Buy
+1,830
New +$145K 0.01% 382
2025
Q2
Sell
-1,842
Closed -$126K 556
2025
Q1
$126K Sell
1,842
-59
-3% -$4.82K 0.01% 341
2024
Q4
$148K Buy
1,901
+19
+1% +$1.41K 0.02% 315
2024
Q3
$126K Sell
1,882
-721
-28% -$59.2K 0.01% 437
2024
Q2
$295K Buy
2,603
+25
+1% +$3.16K 0.03% 243
2024
Q1
$358K Buy
2,578
+33
+1% +$4.15K 0.04% 220
2023
Q4
$316K Buy
2,545
+265
+12% +$27.1K 0.04% 223
2023
Q3
$213K Sell
2,280
-1
-0% -$113 0.03% 263
2023
Q2
$293K Sell
2,281
-20
-0.9% -$2.42K 0.05% 218
2023
Q1
$267K Buy
2,301
+221
+11% +$24.7K 0.05% 225
2022
Q4
$236K Sell
2,080
-24
-1% -$2.63K 0.04% 236
2022
Q3
$169K Buy
2,104
+60
+3% +$5.08K 0.04% 268
2022
Q2
$152K Buy
2,044
+28
+1% +$2.56K 0.03% 274
2022
Q1
$258K Buy
2,016
+464
+30% +$50.8K 0.05% 231
2021
Q4
$208K Buy
+1,552
New +$223K 0.04% 285

Other funds holding DXCM

Quent Capital's DXCM Position: Q1 2026 in Review

Quent Capital reduced its DexCom (DXCM) stake by 30% in Q1 2026, selling an estimated $36.5K and leaving 1,234 shares worth $77.5K. The position accounts for 0.01% of the portfolio, ranked #611.

Quent Capital first reported a position in DXCM in Q4 2021 and has held it in 17 quarters since. The position peaked at $358K in Q1 2024. 957 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Quent Capital held 1,234 shares of DexCom worth $77.5K as of Q1 2026.
  • Quent Capital sold 524 DexCom shares in Q1 2026, an estimated $36.5K.
  • DexCom made up 0.01% of Quent Capital's portfolio in Q1 2026, its #611 holding.
  • Quent Capital first reported a position in DexCom in Q4 2021 and has held it in 17 quarters since.
  • Quent Capital's DexCom position peaked at $358K in Q1 2024.
  • 957 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Quent Capital's 13F filing for Q1 2026, filed 28 Apr 2026.